74 related articles for article (PubMed ID: 26479175)
1. Emerging targets in sarcoma: Rising to the challenge of RAS signaling in undifferentiated pleomorphic sarcoma.
Dodd RD
Cancer; 2016 Jan; 122(1):17-9. PubMed ID: 26479175
[No Abstract] [Full Text] [Related]
2. RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas.
Serrano C; Romagosa C; Hernández-Losa J; Simonetti S; Valverde C; Moliné T; Somoza R; Pérez M; Vélez R; Vergés R; Domínguez R; Carles J; Ramón Y Cajal S
Cancer; 2016 Jan; 122(1):99-107. PubMed ID: 26479291
[TBL] [Abstract][Full Text] [Related]
3. Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes.
Ranginwale M; Smith S; Flom J; Chie L; Kanovsky M; Chung D; Friedman FK; Robinson RC; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
Exp Cell Res; 2001 Sep; 269(1):162-9. PubMed ID: 11525649
[TBL] [Abstract][Full Text] [Related]
4. Cell type-specific importance of ras-c-raf complex association rate constants for MAPK signaling.
Kiel C; Serrano L
Sci Signal; 2009 Jul; 2(81):ra38. PubMed ID: 19638615
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
Romerio F; Riva A; Zella D
Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
[TBL] [Abstract][Full Text] [Related]
7. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3'-digallate.
Chung JY; Park JO; Phyu H; Dong Z; Yang CS
FASEB J; 2001 Sep; 15(11):2022-4. PubMed ID: 11511526
[TBL] [Abstract][Full Text] [Related]
9. Cell biology. Ras on the roundabout.
Meder D; Simons K
Science; 2005 Mar; 307(5716):1731-3. PubMed ID: 15774748
[No Abstract] [Full Text] [Related]
10. Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells.
Tsakiridis T; Tsiani E; Lekas P; Bergman A; Cherepanov V; Whiteside C; Downey GP
Biochem Biophys Res Commun; 2001 Oct; 288(1):205-11. PubMed ID: 11594774
[TBL] [Abstract][Full Text] [Related]
11. Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway.
Weg-Remers S; Ponta H; Herrlich P; König H
EMBO J; 2001 Aug; 20(15):4194-203. PubMed ID: 11483522
[TBL] [Abstract][Full Text] [Related]
12. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.
Ehrhardt GR; Korherr C; Wieler JS; Knaus M; Schrader JW
Oncogene; 2001 Jan; 20(2):188-97. PubMed ID: 11313946
[TBL] [Abstract][Full Text] [Related]
13. Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene.
Agazie Y; Ischenko I; Hayman M
Oncogene; 2002 Jan; 21(5):697-707. PubMed ID: 11850798
[TBL] [Abstract][Full Text] [Related]
14. The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
Dunn KL; Espino PS; Drobic B; He S; Davie JR
Biochem Cell Biol; 2005 Feb; 83(1):1-14. PubMed ID: 15746962
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
16. p21(ras) stimulates pathways in addition to ERK, p38, and Akt to induce elongation of neurites in PC12 cells.
Burry RW
J Neurosci Res; 2001 Jan; 63(1):45-53. PubMed ID: 11169613
[TBL] [Abstract][Full Text] [Related]
17. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
Tidyman WE; Rauen KA
Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
[TBL] [Abstract][Full Text] [Related]
18. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3091-8. PubMed ID: 12202534
[TBL] [Abstract][Full Text] [Related]
19. Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia.
Arcaroli J; Yang KY; Yum HK; Kupfner J; Pitts TM; Park JS; Strassheim D; Abraham E
J Leukoc Biol; 2002 Sep; 72(3):571-9. PubMed ID: 12223526
[TBL] [Abstract][Full Text] [Related]
20. Regulation of p53 expression by the RAS-MAP kinase pathway.
Agarwal ML; Ramana CV; Hamilton M; Taylor WR; DePrimo SE; Bean LJ; Agarwal A; Agarwal MK; Wolfman A; Stark GR
Oncogene; 2001 May; 20(20):2527-36. PubMed ID: 11420662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
